Phio pharmaceuticals corp phio
Webb10 apr. 2024 · Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression … WebbCorporate Information . We were incorporated in the state of Delaware in 2011 as RXi Pharmaceuticals Corporation. On November 19, 2024, the Company changed its name to Phio Pharmaceuticals Corp., to reflect its transition from a platform company to one that is fully committed to developing groundbreaking immuno-oncology therapeutics.
Phio pharmaceuticals corp phio
Did you know?
WebbPer Share Data Phio Pharmaceuticals Corp. All values updated annually at fiscal year end. Earnings Per Share-12.43: Sales - Tangible Book Value 19.44: Operating Profit-12.64: Working Capital 19.20: WebbWebull offers kinds of Phio Pharmaceuticals Corp stock information, including NASDAQ:PHIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHIO stock news, and many more online research tools to help you make informed decisions. paper trading platform.
Webb29 mars 2024 · MARLBOROUGH, Mass., Nov. 13, 2024 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INSTASYL™) therapeutic platform, today announced that it has commenced a …
Webb22 mars 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology is designed to make immune cells more effective in killing tumor cells. INTASYL is the only self-delivering RNAi technology focused on immuno-oncology therapeutics. Webb11 apr. 2024 · View Phio Pharmaceuticals Corp PHIO investment & stock information. Get the latest Phio Pharmaceuticals Corp PHIO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
WebbCompany profile for Phio Pharmaceuticals Corp. including key executives, insider trading, ownership, revenue and average growth rates. View detailed PHIO description & address.
WebbPHIO - Phio Pharmaceuticals Corp. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save … optomap eye exams in maineWebbLegal Name Phio Pharmaceuticals Corp. Stock Symbol NASDAQ:PHIO Company Type For Profit Contact Email [email protected] Phone Number 5083665877 Phio Pharmaceuticals is a biotechnology company developing immuno-oncology therapeutics based on its self-delivering RNAi (sd-rxRNA) therapeutic platform. portrait of an american small townWebb7 mars 2024 · Comparing Phio Pharmaceuticals (NASDAQ:PHIO) and IVERIC bio (NASDAQ:ISEE) 3/7/2024 - Ticker Report. Phio Pharmaceuticals (NASDAQ:PHIO) Stock Price Up 6.5%. 3/5/2024 - Zolmax. Phio Pharmaceuticals Appoints Robert Bitterman as President and Chief Executive Officer. 2/22/2024 - PR Newswire. optomechanical akhmediev breathersWebbOver the last 12 months, Phio Pharmaceuticals's shares have ranged in value from as little as $3.9 up to $29.04. A popular way to gauge a stock's volatility is its "beta". Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Phio Pharmaceuticals's is 1.4718. portrait of an infpWebbFör 1 dag sedan · Phio Pharmaceuticals Corp. (PHIO) Stock Forecast & Price Targets - Stock Analysis Phio Pharmaceuticals Corp. ( PHIO) NASDAQ · USD Add to Watchlist 5.71 -0.07 (-1.21%) Apr 6, 2024, 4:00 PM EDT - Market closed Overview Financials Statistics Forecast Dividends Profile Chart Stock Price Forecast optomate touch user manualWebbFör 1 dag sedan · PHIO PHARMACEUTICALS CORP. : Financial news and information Stock PHIO PHARMACEUTICALS CORP. Nasdaq: PHIO Nasdaq Advanced search Log in Forgot password ? Remember Or log in with Google Twitter Facebook Apple Sign up Email Registration Or log in with Google Twitter Facebook Apple English (USA) portrait of an actress分段Webb10 maj 2012 · About Phio Pharmaceuticals Corp. (PHIO) Phio is addressing some of the biggest challenges in immuno-oncology (I/O) by developing therapeutics that leverage our INTASYL™ self-delivering technology to target both tumor and immune cells. The I/O field has recently identified several promising next-generation targets, but conventional … portrait of an unknown lady gainza